Clinical Trial: Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants
Study Status: Completed
Recruit Status: RECRUITING
Condition: Generalized Anxiety Disorder (GAD)
Study Type: INTERVENTIONAL
Official Title: Generalized Anxiety Disorder (GAD): A First-in-Human Single Ascending Dose and Food Effect Study of ABBV-932 in Healthy Adult Subjects
Brief Summary:
The main objective of this study is to assess pharmacokinetics, safety, and tolerability of ABBV-932 in healthy adult participants.
Read more